4JPJ

Crystal structure of the germline-targeting HIV-1 gp120 engineered outer domain, eOD-GT6

4JPJ の概要

• エントリーDOI: 10.2210/pdb4jpj/pdb
• 関連するPDBエントリー: 4JPI 4JPK
• 分子名称: Germline-targeting HIV-1 gp120 engineered outer domain, eOD-GT6, 2-acetamido-2-deoxy-beta-D-glucopyranose (3 entities in total)
• 機能のキーワード: hiv-1 gp120, cd4 binding site, vrc01-like broadly neutralizing antibodies, viral protein
• 由来する生物種: Human immunodeficiency virus 1 (HIV-1)
• タンパク質・核酸の鎖数: 4
• 化学式量合計: 81774.25

構造登録者

Julien, J.-P.,Jardine, J.,Schief, W.R.,Wilson, I.A. (登録日: 2013-03-19, 公開日: 2013-04-10, 最終更新日: 2024-11-20)

主引用文献

Jardine, J.,Julien, J.P.,Menis, S.,Ota, T.,Kalyuzhniy, O.,McGuire, A.,Sok, D.,Huang, P.S.,MacPherson, S.,Jones, M.,Nieusma, T.,Mathison, J.,Baker, D.,Ward, A.B.,Burton, D.R.,Stamatatos, L.,Nemazee, D.,Wilson, I.A.,Schief, W.R.
Rational HIV immunogen design to target specific germline B cell receptors.
Science, 340:711-716, 2013

PubMed Abstract: Vaccine development to induce broadly neutralizing antibodies (bNAbs) against HIV-1 is a global health priority. Potent VRC01-class bNAbs against the CD4 binding site of HIV gp120 have been isolated from HIV-1-infected individuals; however, such bNAbs have not been induced by vaccination. Wild-type gp120 proteins lack detectable affinity for predicted germline precursors of VRC01-class bNAbs, making them poor immunogens to prime a VRC01-class response. We employed computation-guided, in vitro screening to engineer a germline-targeting gp120 outer domain immunogen that binds to multiple VRC01-class bNAbs and germline precursors, and elucidated germline binding crystallographically. When multimerized on nanoparticles, this immunogen (eOD-GT6) activates germline and mature VRC01-class B cells. Thus, eOD-GT6 nanoparticles have promise as a vaccine prime. In principle, germline-targeting strategies could be applied to other epitopes and pathogens.

PubMed: 23539181
DOI: 10.1126/science.1234150

実験手法

X-RAY DIFFRACTION (2.5 Å)